U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1723C>T (p.Leu575Phe) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 7, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003159635.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1723C>T (p.Leu575Phe)]

NM_000527.5(LDLR):c.1723C>T (p.Leu575Phe)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1723C>T (p.Leu575Phe)
HGVS:
  • NC_000019.10:g.11116876C>T
  • NG_009060.1:g.32496C>T
  • NM_000527.5:c.1723C>TMANE SELECT
  • NM_001195798.2:c.1723C>T
  • NM_001195799.2:c.1600C>T
  • NM_001195800.2:c.1219C>T
  • NM_001195803.2:c.1342C>T
  • NP_000518.1:p.Leu575Phe
  • NP_000518.1:p.Leu575Phe
  • NP_001182727.1:p.Leu575Phe
  • NP_001182728.1:p.Leu534Phe
  • NP_001182729.1:p.Leu407Phe
  • NP_001182732.1:p.Leu448Phe
  • LRG_274t1:c.1723C>T
  • LRG_274:g.32496C>T
  • LRG_274p1:p.Leu575Phe
  • NC_000019.9:g.11227552C>T
  • NM_000527.4(LDLR):c.1723C>T
  • NM_000527.4:c.1723C>T
  • p.Leu575Phe
Protein change:
L407F
Links:
dbSNP: rs1205480064
NCBI 1000 Genomes Browser:
rs1205480064
Molecular consequence:
  • NM_000527.5:c.1723C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1723C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1600C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.1219C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.1342C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003912554Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 7, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The use of targeted exome sequencing in genetic diagnosis of young patients with severe hypercholesterolemia.

Jiang L, Wu WF, Sun LY, Chen PP, Wang W, Benito-Vicente A, Zhang F, Pan XD, Cui W, Yang SW, Zhou YJ, Martin C, Wang LY.

Sci Rep. 2016 Nov 10;6:36823. doi: 10.1038/srep36823.

PubMed [citation]
PMID:
27830735
PMCID:
PMC5103295

Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry.

Chiou KR, Charng MJ.

J Clin Lipidol. 2017 Mar - Apr;11(2):386-393.e6. doi: 10.1016/j.jacl.2016.12.014. Epub 2017 Jan 10.

PubMed [citation]
PMID:
28502495
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV003912554.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The p.L575F variant (also known as c.1723C>T), located in coding exon 12 of the LDLR gene, results from a C to T substitution at nucleotide position 1723. The leucine at codon 575 is replaced by phenylalanine, an amino acid with highly similar properties. This variant has been detected in familial hypercholesterolemia (FH) and mixed dyslipidemia cohorts; however, details were limited (Chiou KR et al. J Clin Lipidol, 2017 Jan;11:386-393.e6; Huang CC et al. J Atheroscler Thromb, 2022 May;29:639-653; Dron JS et al. BMC Med Genomics, 2020 Feb;13:23). This variant co-occurred with a second LDLR variant in a homozygous FH cohort; however, details were limited (Jiang L et al. Sci Rep, 2016 Nov;6:36823; Du Z et al. iScience, 2022 Nov;25:105334). Functional studies by one group suggest this variant may result in a moderate reduction in protein function (Jiang L et al. Sci Rep, 2016 Nov;6:36823). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024